Authors' reply to Shetty
Author:
Affiliation:
1. Section of Molecular Diagnostics, Pathology, Rajiv Gandhi Cancer Institute and Research Center, New Delhi, Delhi, India
2. Medical Oncology, Rajiv Gandhi Cancer Institute and Research Center, New Delhi, Delhi, India
Publisher
Medknow
Subject
Cancer Research,Oncology (nursing),Drug Guides,Oncology
Reference10 articles.
1. Challenges and breakthroughs: ALK alteration detection in non-small-cell lung carcinoma;Shetty;Cancer Res Stat Treat,2023
2. Testing modalities for ALK-driven lung cancer: A narrative review;Nathany;Cancer Res Stat Treat,2023
3. Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer;Soda;Nature,2007
4. Treatment of advanced non-small-cell lung cancer: First line, maintenance, and second line– Indian consensus statement update (Under the aegis of Lung Cancer Consortium Asia, Indian Cooperative Oncology Network, Indian Society of Medical and Pediatric Oncology, Molecular Oncology Society, and Association of Physicians of India);Prabhash;Cancer Res Stat Treat,2021
5. Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology;Lindeman;J Thorac Oncol,2013
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3